PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2022; 13(4): e0024. ISSN: 2076-9172Published online 2022 October 27. doi: 10.5041/RMMJ.10483.

Table 2.

Computed Tomography and Magnetic Resonance Imaging Patterns in Patients and Mortality.

#	Patient Information (Age, Sex, Admission Details, Diabetes Status, Imaging)	Stage⁸	Perianthral Cellular Tissue Invasion	Bone Destruction	Orbit Involvement	Optic Nerve Invasion	Spread to Palate Fossa	Nasolacrimal Duct and Lacrimal Sac Invasion	Intracranial Structures Involvement	ROCM Mortality
1	62, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT + MRI	3C	+	+	+	+	+	−	+	−
2	39, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D^*, CT	2B	+	+	+	+	+	−	−	−
3	60, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D^*, CT	2A	+	+	+	−	−	−	−	+
4	42, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D^*, CT	2B	+	+	+	−	+	−	−	+
5	57, M, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	2A	+	+	+	−	+	−	−	−
6	58, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	1B	+	+	−	−	+	−	−	−
7	48, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	2B	+	+	−	−	+	+	−	−
8	69, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D (diabetic coma), CT + MRI	3B	+	+	+	+	−	−	+	+
9	74, F, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	3A	−	+	+	−	−	−	−	−
10	67, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	2A	−	+	+	−	−	−	+	-
11	73, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	2A	−	−	+	+	−	−	−	−
12	56, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	2B	−	+	−	−	−	+	−	−
13	69, M, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	1B	−	+	+	−	−	−	−	−
14	66, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D (diabetic coma), CT + MRI	3A	+	+	+	+	−	−	+	−
15	49, F, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	2B	+	+	+	+	−	−	−	−
16	74, F, ROCM S/Sx while hospitalized with COVID-19, T2D, CT	2B	−	+	+	+	−	−	−	−
17	63, F, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	1B	+	+	−	−	−	−	−	−
18	62, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D (diabetic coma), CT + MRI	3B	−	+	+	+	+	+	+	+
19	58, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D, CT	2B	−	+	+	+	−	−	−	−
20	70, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D (severe form), CT + MRI	3B	−	+	+	−	+	+	+	−
21	62, M, ROCM S/Sx while hospitalized with COVID-19, T2D^*, CT	2B	−	+	+	+	−	−	−	−
22	68, M, admitted for ROCM S/Sx after COVID-19 discharge, T2D (severe form), CT	3A	+	+	+	+	−	−	+	+
23	55, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D^*, CT	1B	−	+	−	−	−	−	−	−
24	60, F, admitted for ROCM S/Sx after COVID-19 discharge, T2D^*, CT	1A	−	+	−	−	−	−	−	−

^*Type 2 diabetes (T2D) first identified during hospitalization with COVID-19.

+, present; −, not present; COVID-19, coronavirus disease 2019; CT, computed tomography; F, female; M, male; MRI, magnetic resonance imaging; ROCM, rhinoorbitocerebral mucormycosis; S/Sx, signs and symptoms; T2D, type 2 diabetes.